CANTON, Mass., Sept. 04, 2024 (GLOBE NEWSWIRE) — Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today announced that management will participate in the following upcoming investor conferences:
The Morgan Stanley Global Healthcare Conference at the New York Marriott Marquis in New York, NY
- Management will participate in investor 1×1 meetings. There will be no formal presentation.
The Cantor Fitzgerald Global Healthcare Conference at the InterContinental Barclay Hotel in New York, NY
- Management will participate in a fireside chat on Wednesday, September 18 at 1:20 p.m. Eastern Time.
A webcast of the conference presentation will be accessible by visiting the “Upcoming Events” section on the “Investor Relations” page of Organogenesis’s website www.organogenesis.com. An archive of the webcast will be available for replay following the conference for approximately 30 days.
About Organogenesis Holdings Inc.
Organogenesis Holdings Inc. is a leading regenerative medicine company focused on the development, manufacture, and commercialization of solutions for the advanced wound care and surgical and sports medicine markets. Organogenesis offers a comprehensive portfolio of innovative regenerative products to address patient needs across the continuum of care. For more information, visit www.organogenesis.com
CONTACT: Investor Inquiries: ICR Westwicke Mike Piccinino, CFA [email protected] Press and Media Inquiries: Organogenesis [email protected]
- Kim Brandt Joins Noridian’s Board of Directors - September 17, 2024
- Mark Cuban Foundation and Headstorm Bring Free AI Bootcamp to Addison Teens - September 17, 2024
- It’s Vegas, Baby: Systics Gives Workday Rising 2024 Attendees a Sneak Peek at Powerful New Tech - September 17, 2024
